ELIXOPHYLLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Elixophyllin, and what generic alternatives are available?
Elixophyllin is a drug marketed by Forest Labs and Nostrum Labs Inc and is included in four NDAs.
The generic ingredient in ELIXOPHYLLIN is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Elixophyllin
A generic version of ELIXOPHYLLIN was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ELIXOPHYLLIN?
- What are the global sales for ELIXOPHYLLIN?
- What is Average Wholesale Price for ELIXOPHYLLIN?
Summary for ELIXOPHYLLIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,979 |
| DailyMed Link: | ELIXOPHYLLIN at DailyMed |
Recent Clinical Trials for ELIXOPHYLLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University Medical Center | Phase 2 |
Pharmacology for ELIXOPHYLLIN
| Drug Class | Methylxanthine |
US Patents and Regulatory Information for ELIXOPHYLLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | ELIXOPHYLLIN | theophylline | CAPSULE;ORAL | 085545-001 | Jul 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Forest Labs | ELIXOPHYLLIN SR | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 086826-001 | Jan 29, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Forest Labs | ELIXOPHYLLIN | theophylline | CAPSULE;ORAL | 083921-001 | Jul 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
